Previous Section
Drug Therapy
1. Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.
- Author
- Martin-Salces M; Canales MA; de Paz R; Hernandez-Navarro F;
- Institution
- Journal
- Leuk Res. 2008 Jan;32(1):199-200. Epub 2007 Sep 17.
2. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.
- Author
- Zhang WG; Wang FX; Chen YX; Cao XM; He AL; Liu J; Ma XR; Zhao WH; Liu SH; Wang JL;
- Institution
- Department of Hematology and Oncology, The Second Affiliated Hospital, Xi'an JiaoTong University, Xi'an, People's Republic of China. zhangwanggang2003@yahoo.com
- Journal
- Am J Hematol. 2008 Mar;83(3):185-8.
- Abstract URL
- Click here to view abstract
3. A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients.
- Author
- Olivieri A; Capelli D; Troiani E; Poloni A; Montanari M; Offidani M; Discepoli G; Leoni P;
- Institution
- Department of Hematology, Medical School, University of Ancona, Ancona, Italy. attilo.olivieri@ospedalesancarlo.it
- Journal
- Exp Hematol. 2007 Jul;35(7):1074-82.
- Abstract URL
- Click here to view abstract
4. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
- Author
- Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Holowiecki J; Kyrcz-Krzemien S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kielbinski M; Zawilska K; Kloczko J; Wrzesien-Kus A;
- Institution
- Department of Hematology, Medical University, Lodz, Poland.
- Journal
- Eur J Haematol. 2008 Feb;80(2):115-26. Epub 2007 Dec 11.
- Abstract URL
- Click here to view abstract
5. Tipifarnib in acute myeloid leukemia.
- Author
- Burnett AK; Kell J;
- Institution
- Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK. BurnettAK@Cardiff.ac.uk
- Journal
- Drugs Today (Barc). 2007 Nov;43(11):795-800.
- Abstract URL
- Click here to view abstract
6. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.
- Author
- Hamalainen S; Kuittinen T; Matinlauri I; Nousiainen T; Koivula I; Jantunen E;
- Institution
- Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
- Journal
- Leuk Lymphoma. 2008 Mar;49(3):495-501.
- Abstract URL
- Click here to view abstract
7. Recombinant granulocyte-colony stimulating factor as treatment for poor prognosis oligoblastic acute myeloid leukemia in elderly patients.
- Author
- Pelizzari AM; Drera M; D'Adda M; Ungari M; Marocolo D; Facchetti F; Bellotti D; Barlati S; Rossi G;
- Institution
- Divisione Ematologia, Spedali Civili P. le Spedali Civili, 1 25123 Brescia, Italy.
- Journal
- Haematologica. 2007 Jan;92(1):106-9.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
